IAS 36 para 129, disclosure of impairments and reversals by segment GlaxoSmithKline plc – Annual report – 31 December 2017 Industry: pharmaceuticals Segment information (extract) Advertisements Share this:TwitterFacebookLike this:Like Loading...
